Pharma with Duke University roots files to go public

A clinical-stage pharmaceutical firm with Duke University roots has filed paperwork to go public in an $86.3 million offering – one that could mean a windfall for a Triangle investor. PhaseBio Pharmaceuticals, which spun out of Duke University in 2002 and counts Durham's Hatteras Venture Partners as a backer, relocated its headquarters from Durham to Pennsylvania in 2010. Late Friday, the company, which focuses on trea ting rare diseases – particularly in the cardiopulmonary space – filed…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news